MR spectroscopy of the fetal brain: Is it possible without sedation?

American Journal of Neuroradiology

Volumn 34, Issue 2, 2013, Pages 424-431

  Berger Kulemann, Vanessa ^a   Brugger, P C ^a   Pugash, D ^b   Krssak, M ^a   Weber, M ^a   Wielandner, A ^a   Prayer, D ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATININE; INOSITOL;

ARTICLE; BRAIN DISEASE; BREECH PRESENTATION; CEPHALIC PRESENTATION; FEASIBILITY STUDY; FETUS; FETUS DISEASE; GENERAL ANESTHESIA; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; PROTON NUCLEAR MAGNETIC RESONANCE; QUALITATIVE ANALYSIS; REPRODUCTION; RETROSPECTIVE STUDY; SEDATION; SIGNAL NOISE RATIO; SINGLE VOXEL SPECTROSCOPY; SPECTROSCOPY;

ASPARTIC ACID; BRAIN; CHOLINE; CONSCIOUS SEDATION; CREATINE; FEMALE; FETAL DISEASES; FETAL GROWTH RETARDATION; GESTATIONAL AGE; HUMANS; INOSITOL; LABOR PRESENTATION; MAGNETIC RESONANCE SPECTROSCOPY; MOVEMENT; PREGNANCY; PRENATAL DIAGNOSIS; PROTONS; RETROSPECTIVE STUDIES; SIGNAL-TO-NOISE RATIO;

EID: 84876166570     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A3196     Document Type: Article

References (34)

1. Pugash D, Krssak M, Kulemann V, et al. Magnetic resonance spectroscopy of the fetal brain. Prenat Diagn 2009;29:434-41
2. Huppi PS, Amato M. Advanced magnetic resonance imaging techniques in perinatal brain injury. Biol Neonate 2001;80:7-14 (Pubitemid 32727519)
3. Toft PB, Leth H, Lou HC, et al. Metabolite concentrations in the developing brain estimated with proton MR spectroscopy. J Magn Reson Imaging 1994;4:674-80
4. Cady EB, Amess P, Penrice J, et al. Early cerebral-metabolite quantification in perinatal hypoxic-ischaemic encephalopathy by proton and phosphorus magnetic resonance spectroscopy. Magn Reson Imaging 1997;15:605-11 (Pubitemid 27327269)
5. Girard N, Gouny SC, Viola A, et al. Assessment of normal fetal brain maturation in utero by proton magnetic resonance spectroscopy. Magn Reson Med 2006;56:768-75 (Pubitemid 44477660)
6. Kok RD, Steegers-Theunissen RP, Eskes TK, et al. Decreased relative brain tissue levels of inositol in fetal hydrocephalus. Am J Obstet Gynecol 2003;188:978-80 (Pubitemid 36530048)
7. Azpurua H, Alvarado A, Mayobre F, et al. Metabolic assessment of the brain using proton magnetic resonance spectroscopy in a growth-restricted human fetus: case report. Am J Perinatol 2008;25:305-09
8. Astley SJ, Richards T, Aylward EH, et al. Magnetic resonance spectroscopy outcomes from a comprehensive magnetic resonance study of children with fetal alcohol spectrum disorders. MagnReson Imaging 2009;27:760-78
9. Roelants-van Rijn AM, Groenendaal F, Stoutenbeek P, et al. Lactate in the foetal brain: detection and implications. Acta Paediatr 2004;93:937-40 (Pubitemid 38829838)
10. 1H-MRS using different echo times in neonates with cerebral hy-poxia- ischemia. Pediatr Res 2001;49:356-62
11. Brunel H, Girard N, Confort-Gouny S, et al. Fetal brain injury. J Neuroradiol 2004;31:123-37 (Pubitemid 38374228)
12. Gerards FA, Stoutenbeek P, Gooskens RH, et al. Diagnostic value of prenatal MRI in fetus with intracranial anomalies diagnosed by ultrasonography [in Dutch]. Ned Tijdschr Geneeskd 2001;145:179-84 (Pubitemid 33653208)
13. Kostović I, Judas M, Rados M, et al. Laminar organization of the humanfetal cerebrum revealed by histochemical markers and magnetic resonance imaging. Cereb Cortex 2002;12:536-44 (Pubitemid 34578668)
14. Kasprian G, Brugger PC, Weber M, et al. In utero tractography of fetal white matter development. Neuroimage 2008;43:213-24
15. Kanto J, Erkkola R, Kangas L, et al. Placental transfer of flunitrazepam following intramuscular administration during labour. Br J Clin Pharmacol 1987;23:491-94 (Pubitemid 17108183)
16. Oelschläger H. Chemical and pharmacologic aspects of benzodiazepines [in German]. Schweiz Rundsch Med Prax 1989:78:766-72
17. Kanto JH. Use of benzodiazepines during pregnancy, labour and lactation, with particular reference to pharmacokinetic considerations. Drugs 1982:23:354-80 (Pubitemid 12053642)
18. Hindmarch I. A repeated dose comparison of three benzodiazepine derivative (nitrazepam, flurazepam and flunitrazepam) on subjective appraisals of sleep and measures of psychomotor performance the morning following night-time medication. Acta Psychiatr Scand 1977:56: 373-81 (Pubitemid 8225424)
19. Prayer D, Kasprian G, Krampl E, et al. MRI of normal fetal brain development. Eur J Radiol 2006;57:199-216 (Pubitemid 43183650)
20. Legido A, Valencia I, Smith JD. Fetal neurological evaluation [in Spanish]. Rev Neurol 2004:15;39:454-64 (Pubitemid 39472037)
21. Counsell SJ, Maalouf EF, Fletcher AM, et al. MRimaging assessment of myelination in the very preterm brain. AJNR Am J Neuroradiol 2002;23:872-81 (Pubitemid 34525711)
22. Huang H, Zhang J, Wakana S, et al. White and gray matter development in human fetal, newborn and pediatric brains. Neuroimage 2006:15;33:27-38 (Pubitemid 44397586)
23. Madhavarao CN, Hammer JA, Quarles RH, et al. Aradiometric assay for aspartoacylase activity in cultured oligodendrocytes. Anal Biochem 2002;308:314-19 (Pubitemid 35177145)
24. Kirmani BF, Jacobowitz DM, Namboodiri MA. Developmental increase of aspartoacylase in oligodendrocytes parallels CNS myelination. Brain Res Dev Brain Res 2003;140:105-15 (Pubitemid 36084341)
25. Kato T, Nishina M, Matsushita K, et al. Neuronal maturation and N-acetyl-L-aspartic acid development in human fetal and child brains. Brain Dev 1997;19:131-33 (Pubitemid 27135936)
26. Kok RD, van den Berg PP, van den Bergh AJ, et al. Maturation of the human fetal brain as observed by 1HMRspectroscopy. Magn Reson Med 2002;48:611-16
27. Girard N, Fogliarini C, Viola A, et al. MRS of normal and impaired fetal brain development. Eur J Radiol 2006;57:217-25 (Pubitemid 43183651)
28. Heerschap A, Kok RD, van den Berg PP. Antenatal proton MR spectroscopy of the human brain in vivo. Childs Nerv Syst 2003;19:418-21 (Pubitemid 37161581)
29. Kreis R, Hofmann L, Kuhlmann B, et al. Brain metabolite composition during early human brain development as measured by quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med 2002;48:949-58 (Pubitemid 35398524)
30. Story L, Damodaram MS, Allsop JM, et al. Brain metabolism in fetal intrauterine growth restriction: a proton magnetic resonance spectroscopy study. Am J Obstet Gynecol 2011;205:483.e1-8
31. Charles-Edwards GD, Jan W, To M, et al. Non-invasive detection and quantification of human foetal brain lactate in utero by magnetic resonance spectroscopy. Prenat Diagn 2010;30:260-66
32. Wolfberg AJ, Robinson JN, Mulkern R, et al. Identification of cerebral lactate using magnetic resonance spectroscopy. Am J Obstet Gynecol 2007;196:e9-11
33. Moxon-Lester L, Sinclair K, Burke C, et al. Increased cerebral lactate during hypoxia may be neuroprotective in newborn piglets with intrauterine growth restriction. Brain Res 2007;1179:79-88
34. Taberno A, Vicario C, Medina JM. Lactate spares glucose as a metabolic fuel in neurons and astrocytes from primary culture. Neurosci Res 1996;26:369-76 (Pubitemid 27010776)